Complete Genomics Competitors and Similar CompaniesClear all

Personalis's competitors and similar companies include 23andMe.
Personalis
Personalis
Personalis is a biotechnology company that specializes in cancer genomics.
23andMe
23andMe
23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.
Founding Date
Founding Date
2011
Founding Date
2006
Type
Type
Public
Type
Public
Tags
Locations
Locations
Fremont, US HQ
West Wickham, GB
Locations
Sunnyvale, US HQ
South San Francisco, US
Employees
Employees
22344% decrease
Employees
56027% decrease
Valuation ($)
Valuation ($)
340.9 m
Valuation ($)
169.1 m

Financial

Revenue (est.)
Revenue (est.)
$69.6m (FY, 2025)
Revenue (est.)
$189.9m (FY, 2025)
Cost of goods
Cost of goods
$53.9m (FY, 2025)
Cost of goods
$89.9m (FY, 2025)
Gross profit
Gross profit
$15.8m (FY, 2025)
Gross profit
$100m (FY, 2025)
Net income
Net income
($81.3m) (FY, 2025)
Net income
($280.9m) (FY, 2025)

Operating

Patents Issued
Patents Issued
16 (FY, 2021)
Patents Issued
93 (FY, 2022)

Funding

Total funding raised
Total funding raised
$ 75m
Total funding raised
$ 912.5m
For sources of this data, please see the company profile

View Company Profiles

23andMe
HQ
Sunnyvale, US
Employees
560↓ 27% decrease

23andMe Holding (formerly known as VG Acquisition) is a consumer genetics and research company.

View company